Skip to main content
Daily Report

Daily Sepsis Research Analysis

08/24/2025
3 papers selected
3 analyzed

Three studies advance sepsis care across diagnostics and hemodynamics: a rapid intraoperative chip detects viable pathogens in 15 minutes, a PRISMA-registered systematic review supports LVOT VTI for fluid responsiveness in sepsis/septic shock, and a pilot study shows higher albumin transudation (endothelial leak) in sepsis versus COVID-19 with frequent volume status misclassification.

Summary

Three studies advance sepsis care across diagnostics and hemodynamics: a rapid intraoperative chip detects viable pathogens in 15 minutes, a PRISMA-registered systematic review supports LVOT VTI for fluid responsiveness in sepsis/septic shock, and a pilot study shows higher albumin transudation (endothelial leak) in sepsis versus COVID-19 with frequent volume status misclassification.

Research Themes

  • Rapid intraoperative pathogen detection and viability assessment
  • Ultrasound-based hemodynamic monitoring (LVOT VTI) for fluid responsiveness
  • Endothelial dysfunction and capillary leak quantification in critical illness

Selected Articles

1. Intraoperative pathogen rapid detection on chip.

76Level IICohort
Biosensors & bioelectronics · 2025PMID: 40848337

The chip-based IPRD integrates AI-assisted microscopy and electroporation-LAMP to provide 15-minute, intraoperative, multi-parameter pathogen detection, including viability and species ID, with 99.01% accuracy on clinical samples. It targets purulent fluids found during surgery, offering actionable guidance to prevent postoperative sepsis.

Impact: Represents a significant diagnostic innovation enabling real-time, intraoperative pathogen and viability detection that could change source control and antibiotic decisions.

Clinical Implications: Could enable on-table tailoring of antibiotics and surgical management to reduce postoperative sepsis risk by rapidly identifying viable pathogens and species intraoperatively.

Key Findings

  • 15-minute intraoperative detection of presence, viable fraction, species, and concentration of multiple pathogens on-chip
  • Dual-module design: AI-assisted live/dead quantification and electroporation-LAMP nucleic acid detection
  • Clinical validation achieved 99.01% accuracy; reliably detected Candida albicans, Escherichia coli, and Enterococcus faecalis

Methodological Strengths

  • Integrates phenotypic live/dead assessment with genotypic LAMP detection
  • Clinical validation demonstrating high accuracy within intraoperative workflow

Limitations

  • Sample size and breadth of species panel not specified in the abstract
  • Clinical validation scope (e.g., comparison with culture turnaround and outcomes) not detailed

Future Directions: Prospective intraoperative trials comparing IPRD-guided decisions versus standard culture to assess antibiotic timing, source control, and postoperative sepsis outcomes; expansion of species panel and direct blood applicability.

During surgery, purulent fluid containing pathogens may be found at the surgical site. Pathogens in purulent fluid can cause sepsis if disseminated into the bloodstream. Therefore, intraoperative detection of pathogens in purulent fluid is critical for guiding surgeons in selecting surgical management and antibiotic therapy. However, current detection methods are either time-consuming or unable to identify live pathogens, restricting their clinical application in intraoperative settings. To overcome these limitations, we proposed an intraoperative pathogen rapid detection (IPRD) method. This method can simultaneously detect the presence, viable fraction, species, and concentrations of multiple pathogens in 15 min. This method is performed on a chip with two parts: a single-channel part combines live/dead staining with AI-assisted microscopy to quantify live pathogens, and a parallel-channel part uses electroporation-based lysis followed by LAMP assay for nucleic acid detection. This method demonstrated an accuracy of 99.01 % in clinical validation, reliably detecting Candida albicans, Escherichia coli, and Enterococcus faecalis at 10

2. Utilization of left ventricular outflow tract velocity time integral in the assessment of fluid responsiveness in adult patients with sepsis or septic shock - a systematic review.

74Level ISystematic Review
Journal of ultrasound · 2025PMID: 40849404

Across three observational studies (n=199), LVOT VTI changes after PLR or 500 mL saline predicted fluid responsiveness in sepsis/septic shock with sensitivity 78–96%, specificity 91–100%, and AUC 0.84–0.99. The PRISMA-registered review supports integrating LVOT VTI into bedside protocols while acknowledging limited evidence volume.

Impact: Provides a consolidated, methodologically transparent appraisal of LVOT VTI for fluid responsiveness in sepsis, offering actionable cutoffs and performance metrics.

Clinical Implications: Supports using LVOT VTI changes with PLR or small-volume expansion to guide individualized resuscitation in sepsis/septic shock, potentially reducing fluid-related harm.

Key Findings

  • Three observational studies (n=199) showed LVOT VTI predicts fluid responsiveness in sepsis/septic shock
  • Optimal cutoffs ranged >7% to 16% change in VTI; sensitivity 78–96%, specificity 91–100%, AUC 0.84–0.99
  • PRISMA 2020 compliance and PROSPERO registration (CRD420251036927); two studies rated good quality

Methodological Strengths

  • PRISMA-guided search across six databases with PROSPERO registration
  • Standardized definitions (≥10–15% VTI increase) and quality assessment (Newcastle-Ottawa Scale)

Limitations

  • Only three studies with heterogeneous protocols (PLR vs. VET and cutoff thresholds)
  • All observational; no randomized comparisons or outcome-linked protocols

Future Directions: Prospective, protocolized trials testing LVOT VTI–guided fluid strategies on patient-centered outcomes; standardization of acquisition and training to reduce variability.

BACKGROUND: Sepsis and septic shock are life-threatening conditions driven by dysregulated host responses to infection, resulting in multi-organ dysfunction. While early fluid resuscitation is essential, both fluid overload and under-resuscitation can worsen outcomes. Left Ventricular Outflow Tract Velocity Time Integral (LVOT VTI) has emerged as a non-invasive echocardiographic tool to assess fluid responsiveness. This systematic review evaluates the diagnostic performance, cutoff values, and limitations of LVOT VTI as a tool for assessing fluid responsiveness in adult patients with sepsis or septic shock. METHODS: A systematic search of PubMed, Cochrane, Scopus, Web of Science, EMBASE, and CINAHL was conducted through April 13, 2025, following PRISMA 2020 guidelines (PROSPERO ID: CRD420251036927). Eligible studies used transthoracic or transesophageal echocardiography to measure LVOT VTI and assessed changes following passive leg raise (PLR) or volume expansion tests (VET). Fluid responsiveness was defined as a ≥ 10-15% increase in VTI. RESULTS: Three observational studies including 199 adult patients (20 with sepsis, 179 with septic shock) met inclusion criteria. Two studies used VET (500 mL saline), and one used PLR. Optimal LVOT VTI cutoffs ranged from > 7% to 16%, with sensitivity 78-96%, specificity 91-100%, and AUCs 0.84-0.99. Based on the Newcastle-Ottawa Scale, two studies were rated good quality, and one was fair. CONCLUSION: LVOT VTI is a reliable, non-invasive parameter for assessing fluid responsiveness in sepsis and septic shock. Despite limited data, this review supports its integration into bedside fluid management protocols to guide individualized resuscitation strategies. PROSPERO REGISTRATION ID: CRD420251036927.

3. Endothelial dysfunction in critically ill patients with sepsis and COVID-19 using the albumin transudation rate: A pilot study.

60.5Level IIICohort
Journal of critical care · 2026PMID: 40849980

In 36 ICU patients, albumin transudation rate was persistently elevated in both conditions but higher in sepsis than COVID-19, indicating more pronounced endothelial dysfunction. Bedside assessments frequently misclassified total blood volume, suggesting a need for objective tools to guide fluid therapy.

Impact: Introduces ATR as a practical biomarker of endothelial leak in critical illness and reveals systematic inaccuracies in clinical volume assessment in sepsis.

Clinical Implications: Supports incorporating objective leak/volume metrics into fluid management; ATR or similar measures may refine resuscitation strategies beyond clinical gestalt.

Key Findings

  • ATR remained elevated in both sepsis and COVID-19, and was significantly higher in sepsis throughout ICU stay
  • Despite lower admission severity scores, sepsis patients exhibited greater endothelial dysfunction than COVID-19
  • Clinical assessments frequently misclassified total blood volume, often labeling hypovolemic patients as hypervolemic

Methodological Strengths

  • Multicenter ICU study with repeated measures (Days 1, 2, 3, 7, 10)
  • Objective quantification of TBV, RBCV, and PV alongside ATR

Limitations

  • Pilot sample size (n=36) limits precision and generalizability
  • Measurement methodology details truncated in abstract; not linked to patient-centered outcomes

Future Directions: Larger prospective studies to validate ATR thresholds, correlate with outcomes, and compare against clinical assessments and ultrasound-guided strategies.

BACKGROUND: COVID-19, sepsis, and septic shock are associated with significant endothelial dysfunction and capillary leakage, posing diagnostic and management challenges in critically ill patients. Capillary leakage, as reflected by the albumin transudation rate (ATR), may have implications for fluid dynamics and patient outcomes in these conditions. We sought to describe and compare ATR in these two related pathologies, but clinically distinct conditions. METHODS: This study was conducted in 2022 across three ICUs and included 36 patients (18 with COVID-19 and 18 with sepsis). The local ethical committees approved the study. ATR, total blood volume (TBV), red blood cell volume (RBCV), and plasma volume (PV) were measured at multiple time points (Days 1, 2, 3, 7, and 10) using a RESULTS: ATR was significantly higher in patients with sepsis compared to those with COVID-19 throughout the ICU stay, despite lower admission severity scores in the sepsis group. Clinical assessments of the volume status frequently misclassify TBV in patients with COVID-19 or sepsis. Patients were often deemed hypervolemic when, by objective measures, they were hypovolemic under both conditions. CONCLUSION: ATR was persistently elevated in critically ill patients with sepsis and COVID-19. Sepsis exhibited significantly higher ATR values, suggesting a more pronounced endothelial dysfunction. There is a frequent inaccuracy in clinical fluid status assessment, which demands more reliable diagnostic tools to better guide fluid therapy in critically ill patients.